Stock Events

Stock Events

Search...

Alnylam Pharmaceuticals (DUL.XETRA) Q4 2025 Earnings

30OctConfirmed

Q3 2025

Q4 2025

-0.48

0.21

0.9

1.59

Details

Expected EPS

0.48488863759999995

Actual EPS

1.590496

Surprise EPS

1.11

Surprise Percent

+228.01%

Description

Alnylam Pharmaceuticals (DUL.XETRA) has reported earnings of 1.590496 per share for Q4 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.